Laval Facility

The IQVIA Laboratories Vaccines facility in Laval, Quebec, features more than 225 specialists in a state-of-the-art, 68,000 square foot BSL-2 certified site.

Download Site Information Sheet

We have experience working with more than 100 vaccine manufacturers worldwide and are synonymous with leading vaccine development services. This expertise has made us the referral lab for prestigious governmental and nongovernmental institutions such as the Bill & Melinda Gates Foundation, CEPI, the U.K. Vaccine Task Force, BARDA, and more than 80 innovative biotechnology companies.

Through our partnership with UK Health Security Agency, we played a determinant role in the struggle against SARS-CoV-2 by developing reference vaccine and drug efficacy assessment assays. We are also a signatory of the World Health Organization’s (WHO) public statement for collaboration on SARS-CoV-2 vaccine development, and our assays have been transferred to laboratories all over the world through the Coalition for Epidemic Preparedness Innovations (CEPI) network. 

State-of-the-Art Facilities

Our state-of-the-art facility design promotes scientific excellence through our team of scientists, highly automated workflows, and data management through Laboratory Information Management System (LIMS) systems to support client studies whether they are research based or require fully validated systems as per required standards, including 21 CFR Part 11 compliance. Documentation is preserved in internal and external archives with restricted access to safeguard data and study materials throughout the retention period.

Quality Management System

Our well-defined quality management system (QMS) seamlessly aligns with regulatory requirements GCLP and GCP standards ensure compliance for our clients and for the studies we support. 

Current Accreditations/Certifications

• GCLP (Vaccines)
• GLP (Beijing)
• AAALAC — Association for Assessment and Accreditation of Laboratory Animal Care (Preclinical Laval and Beijing) 

• CCAC — Canadian Council on Animal Care (Preclinical)
• OLAW — Office of Laboratory Animal Welfare (Preclinical)
• BBL — Belgian Banking License (Gosselies)

Robust Data and Scientific Processes

We support your preclinical and clinical molecule/vaccine candidate development — with data and study sample testing managed by our validated, customized, LIMS and its full audit trail.

Sample Management

Our team provides the same uncompromising attention to detail whether you have 10 samples or a million. Each analytical and data plan is custom crafted to ensure we meet all deliverables for all stakeholders. Customized reporting delivers the specific data results you want, on the schedule you require.

Integrated Approach

IQVIA Laboratories Vaccines global scale and high-volume capabilities combines our high-touch, individualized service with the capacity and global coverage to move even the largest projects forward on time and on budget. All while adhering to regulatory requirements including chain of custody, IATA (International Air Transport Association) shipping guidelines, and sample verification upon receipt. We also provide both long- and short-term sample storage. Our fully integrated approach streamlines the management and handling of your data throughout the sample life cycle, resulting in accurate, actionable, and timely evidence.